Dissemination of Registered COVID-19 Clinical Trials (DIRECCT): a cross-sectional study

Dissemination of Registered COVID-19 Clinical Trials (DIRECCT): a cross-sectional study

Abstract Background The results of clinical trials should be completely and rapidly reported during public health emergencies such as COVID-19. This study aimed to examine when, and where, the results of COVID-19 clinical trials were disseminated throughout the first 18 months of the pandemic. Metho...

Full description

Bibliographic Details
Main Authors: Maia Salholz-Hillel, Molly Pugh-Jones, Nicole Hildebrand, Tjada A. Schult, Johannes Schwietering, Peter Grabitz, Benjamin Gregory Carlisle, Ben Goldacre, Daniel Strech, Nicholas J. DeVito
Format: Article
Language:English
Published: BMC 2023-11-01
Series:BMC Medicine
Subjects:
Clinical trials transparency
COVID-19
Research integrity
Clinical trials
Results reporting
Online Access:https://doi.org/10.1186/s12916-023-03161-6

Internet

https://doi.org/10.1186/s12916-023-03161-6

Similar Items